Back
Nemak SAB de CV Vs. AnaptysBio, Inc. Industry Stock Comparison
Buy
52
NMAKF
Nemak SAB de CV
Last Price:
$0.1855
Seasonality Move:
-0.59%
Sell
47
ANAB
AnaptysBio, Inc.
Last Price:
$57.92
Seasonality Move:
5.3%
Buy
52
Nemak SAB de CV (NMAKF)
is a Buy
Is Nemak SAB de CV a Buy, Sell or Hold?
-
The current Nemak SAB de CV [NMAKF] share price is $0.1855. The Score for NMAKF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
NMAKF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
AnaptysBio, Inc. (ANAB)
is a Sell
Is AnaptysBio, Inc. a Buy, Sell or Hold?
-
The current AnaptysBio, Inc. [ANAB] share price is $57.68. The Score for ANAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ANAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NMAKF Stock Price Chart
What is Nemak SAB de CV's stock price today?
-
The Nemak SAB de CV share price today is $0.1855Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NMAKF is experiencing slight buying pressure.
ANAB Stock Price Chart
What is AnaptysBio, Inc.'s stock price today?
-
The AnaptysBio, Inc. share price today is $57.68The current trend is relatively stagnant and ANAB is experiencing slight selling pressure.
NMAKF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 1.38 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.1859 - 0.1859) | Sell |
| Bollinger Bands (100): | (0.1938 - 0.2138) | Sell |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 46.79 | Sell |
| Chaikin Money Flow: | -120538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.32 - 64.78) | Sell |
| Bollinger Bands (100): | (41.49 - 58.03) | Buy |
NMAKF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.19 | Sell |
| 20-day SMA: | 0.19 | Sell |
| 50-day SMA: | 0.2 | Sell |
| 200-day SMA: | 0.19 | Sell |
| 8-day EMA: | 0.18 | Buy |
| 20-day EMA: | 0.13 | Buy |
| 50-day EMA: | 0.07 | Buy |
| 200-day EMA: | 0.02 | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.51 | Sell |
| 20-day SMA: | 61.65 | Sell |
| 50-day SMA: | 55.97 | Buy |
| 200-day SMA: | 37.84 | Buy |
| 8-day EMA: | 58.76 | Sell |
| 20-day EMA: | 59.68 | Sell |
| 50-day EMA: | 56.33 | Buy |
| 200-day EMA: | 41.98 | Buy |
Nemak SAB de CV Earnings Growth & NMAKF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AnaptysBio, Inc. Earnings Growth & ANAB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.13 per share, a decrease this year of $2.63 per share, and an increase next year of $0.54 per share.
Nemak SAB de CV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||